Rocaltrol and Joint contracture - a phase IV clinical study of FDA data

Summary:

Joint contracture is reported as a side effect among people who take Rocaltrol (calcitriol), especially for people who are female, 60+ old, also take Magnevist, and have Nuclear magnetic resonance imaging abdominal.

The phase IV clinical study analyzes which people have Joint contracture when taking Rocaltrol. It is created by eHealthMe based on reports of 7,521 people who have side effects when taking Rocaltrol from the FDA, and is updated regularly.

What is Rocaltrol?

Rocaltrol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 7,562 Rocaltrol users. Check the latest studies of Rocaltrol.

What is Joint contracture?

Joint contracture (a permanent shortening of a muscle or joint) is found to be associated with 336 drugs and 652 conditions by eHealthMe. Check the latest studies of Joint contracture.

On Jul, 27, 2026

7,521 people reported to have side effects when taking Rocaltrol.
Among them, 30 people (0.4%) have Joint contracture.

Could Rocaltrol cause Joint contracture?

Among these 30 people:

What is the gender of people who have Joint contracture when taking Rocaltrol? *

female: 63.33 %
male: 36.67 %

What is the age of people who have Joint contracture when taking Rocaltrol? *

What are other drugs people take besides Rocaltrol? *

What are other side effects people have besides Joint contracture? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 29 people, 96.67%
Pain: 28 people, 93.33%
Skin Induration (an abnormally hard spot or area on the skin): 27 people, 90.00%
Skin Tightness: 25 people, 83.33%
Scar: 24 people, 80.00%
Joint Range Of Motion Decreased (disease of joint movement): 22 people, 73.33%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 22 people, 73.33%
Skin Hypertrophy (skin cells enlarges): 22 people, 73.33%
General Physical Health Deterioration (weak health status): 20 people, 66.67%
Mobility Decreased (ability to move is reduced): 20 people, 66.67%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 11 people, 36.67%
Anaemia (lack of blood): 6 people, 20.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 5 people, 16.67%
High Blood Pressure: 5 people, 16.67%
Hypotension (abnormally low blood pressure): 4 people, 13.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 13.33%
Bleeding Disorders: 4 people, 13.33%
Breast Cancer: 4 people, 13.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 13.33%
Diabetes: 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rocaltrol and have Joint contracture?

- Check whether Joint contracture is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rocaltrol:

Rocaltrol (7,562 reports)

Browse all side effects of Rocaltrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint contracture:

Joint contracture (336 drugs)

Browse all the conditions that are associated with Joint contracture:

Joint contracture (652 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Rocaltrol) and Rocaltrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.